Ovarian dysfunction and gene-expressed characteristics of female mice caused by long-term exposure to titanium dioxide nanoparticles

Journal of Hazardous Materials

Volumn 243, Issue , 2012, Pages 19-27

  Gao, Guodong ^a,b   Ze, Yuguan ^a   Li, Bing ^a   Zhao, Xiaoyang ^a   Zhang, Ting ^c,d   Sheng, Lei ^a   Hu, Ringhu ^a   Gui, Suxin ^a   Sang, Xuezi ^a   Sun, Qingqing ^a   Cheng, Jie ^a   Cheng, Zhe ^a   Wang, Ling ^a   Tang, Meng ^c,d   Hong, Fashui ^a  

^a SOOCHOW UNIVERSITY   (China)

^b JIANGXI MEDICAL COLLEGE   (China)

^c SOUTHEAST UNIVERSITY   (China)

^d Southeast University   (China)

Author keywords

Fertility; Gene expressed profile; Ovary; Sex hormones; Titanium dioxide nanoparticles

Indexed keywords

FERTILITY; GENE-EXPRESSED PROFILE; OVARY; SEX HORMONES; TITANIUM DIOXIDE NANOPARTICLES;

BIOCHEMISTRY; GENES; HORMONES; MAMMALS; MICROARRAYS; NANOPARTICLES; OXIDES;

TITANIUM DIOXIDE;

ESTRADIOL; MINERAL; NANOPARTICLE; PROGESTERONE; SEX HORMONE; TITANIUM DIOXIDE;

CONCENTRATION (COMPOSITION); FERTILITY; GENE EXPRESSION; GENOTOXICITY; INJURY; NANOTECHNOLOGY; POLLUTION EFFECT; POLLUTION EXPOSURE; PREGNANCY; REPRODUCTIVE HEALTH; RODENT; SEX HORMONE; TITANIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; FERTILITY; GENE EXPRESSION; HISTOPATHOLOGY; LONG TERM EXPOSURE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; OVARY INSUFFICIENCY; OXIDATIVE STRESS; PREGNANCY RATE; PROGESTERONE METABOLISM;

ANIMALS; FEMALE; FERTILITY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GONADAL STEROID HORMONES; MICE; MICE, INBRED ICR; MICROARRAY ANALYSIS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; OVARIAN DISEASES; OVARY; OXIDATION-REDUCTION; PEROXIDES; PREGNANCY; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION; TITANIUM;

MUS;

EID: 84869870900     PISSN: 03043894     EISSN: 18733336     Source Type: Journal    
DOI: 10.1016/j.jhazmat.2012.08.049     Document Type: Article

References (71)

1. Brumfiel G. Nanotechnology: a little knowledge. Nature 2003, 424:246-248.
2. Colvin V.L. The potential environmental impact of engineered nanomaterials. Nat. Biotechnol. 2003, l21:1166-1170.
3. Ding L.H., Stilwell J., Zhang T.T., Elboudwarej O., Jiang H.J., Selegue J.P., Cooke P.A., Gray J.W., Chen F.F. Molecular characterization of the cytotoxic mechanism of multiwall carbon nanotubes and nano-onions on human skin fibroblast. Nano Lett. 2005, 5:2448-2464.
4. Zhang T.T., Stilwell J.L., Gerion D., Ding L.H., Elboudwarej O., Cooke P.A., Gray J.W., Alivisatos A.P., Chen F.F. Cellular effect of high doses of silica-coated quantum dot profiled with high throughput gene expression analysis and high content cellomics measurements. Nano Lett. 2006, 6:800-808.
5. Jiang J., Oberdorster G., Elder E., Gelein R., Mercer P., Biswas P. Does nanoparticle activity depend upon size and crystal phase?. Neurotoxicology 2008, 2:33-42.
6. Afaq F., Abidi P., Matin R., Rahman Q. Cytotoxicity, pro-oxidant effects and antioxidant depletion in rat lung alveolar macrophages exposed to ultrafine titanium dioxide. J. Appl. Toxicol. 1998, 18:307-312.
7. 2 particles: differential responses related to surface properties. Toxicology 2007, 230:90-104.
8. Wang J.X., Zhou G.Q., Chen C.Y., Yu H.W., Wang T.C., Ma Y.M., Jia G., Gao Y.X., Li B., Sun J., Li Y.F., Zhao Y.L., Chai Z.F. Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. Toxicol. Lett. 2007, 168:176-185.
9. 2 particles as a component of nanoparticle risk management. Toxicol. Lett. 2007, 171:99-110.
10. 2 particles. Biol. Trace Elem. Res. 2009, 129:170-180.
11. 2. Nanoscale Res. Lett. 2009, 4:1275-1285.
12. Duan Y.M., Liu J., Ma L.L., Li N., Liu H.T., Wang J., Zheng L., Liu C., Wang X.F., Zhao X.Y., Yan J.Y., Wang S.S., Wang H., Zhang X.G., Hong F.S. Toxicological characteristics of nanoparticulate anatase titanium dioxide in mice. Biomaterials 2010, 31:894-899.
13. 2 and liver DNA from mice in vivo. Nanoscale Res. Lett. 2010, 5:108-115.
14. Cui Y.L., Gong X.L., Duan Y.M., Li N., Hu R.P., Liu H.T., Hong M.M., Zhou M., Wang L., Wang H., Hong F.S. Hepatocyte apoptosis and its molecular mechanisms in mice caused by titanium dioxide nanoparticles. J. Hazard. Mater. 2010, 183:874-880.
15. 2 to mice: liver injury, oxidative stress. Toxicol. Environ. Chem. 2010, 92:175-186.
16. 2 nanoparticles. J. Biomed. Mater. Res. A 2011, 96:221-229.
17. Li N., Duan Y.M., Hong M.M., Zheng L., Fei M., Zhao X.Y., Wang J., Cui Y.L., Liu H.T., Cai J.W., Gong S.J., Wang H., Hong F.S. Spleen injury and apoptotic pathway in mice caused by titanium dioxide nanoparticles. Toxicol. Lett. 2010, 195:161-168.
18. 2 delivered to the abdominal cavity. Biomaterials 2010, 31:99-105.
19. 2 nanoparticles. Biomaterials 2010, 31:8043-8050.
20. Hu R.P., Zheng L., Zhang T., Cui Y.L., Gao G.D., Cheng Z., Cheng J., Hong M.M., Tang M., Hong F.S. Molecular mechanism of hippocampal apoptosis of mice following exposure to titanium dioxide nanoparticles. J. Hazard. Mater. 2011, 191:32-40.
21. 2. J. Exp. Nanosci. 2010, 5:447-462.
22. Gui S.X., Zhang Z.L., Zheng L., Cui Y.L., Liu X.R., Li N., Hong F.S. Molecular mechanism of kidney injury of mice caused by exposure to titanium dioxide nanoparticles. J. Hazard. Mater. 2011, 195:365-370.
23. Stelzer R., Hutz R.J. Gold nanoparticles enter rat ovarian granulosa cells and subcellular organelles, and alter in vitro estrogen accumulation. J. Reprod. Dev. 2009, 55:685-690.
24. Boca S.C., Potara M., Toderas F., Stephan O., Baldeck P.L., Astilean S. Uptake and biological effects of chitosan-capped gold nanoparticles on Chinese hamster ovary cells. Mater. Sci. Eng. C 2011, 31:184-189.
25. Liu X.H., Ding X.Q., Cui Y.G., Chen L., Li H., Chen Z., Gao L., Li Y., Liu J. The effect of calcium phosphate nanoparticles on hormone production and apoptosis in human granulosa cells. Reprod. Biol. Endocrinol. 2010, 8:32-39.
26. Jiang J., Wang J., Zhang X.M., Huo K.F., Wong H.M., Yeung K.W.K., Zhang W.J., Hu T., Chu P.K. Activation of mitogen-activated protein kinases cellular signal transduction pathway in mammalian cells induced by silicon carbide nanowires. Biomaterials 2010, 31:7856-7862.
27. Suzuki H., Toyooka T., Ibuki Y. Simple and easy method to evaluate uptake potential of nanoparticles in mammalian cells using a flow cytometric light scatter analysis. Environ. Sci. Technol. 2007, 41(8):3018-3024.
28. Di Virgilio A.L., Reigosa M., Arnal P.M., Fernández Lorenzo de Mele M. Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells. J. Hazard. Mater. 2010, 177:711-718.
29. 3+ ions for photocatalysis. Mater. Lett. 2002, 57:794-801.
30. National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals 1996, National Academy Press, Washington, DC.
31. Sang X.Z., Zheng L., Sun Q.Q., Li N., Cui Y.L., Hu R.P., Gao G.D., Cheng Z., Cheng J., Gui S.X., Liu H.T., Zhang Z.L., Hong F.S. The chronic spleen injury of mice following long-term exposure to titanium dioxide nanoparticles. J. Biomed. Mater. Res. A 2012, 100(4):894-902.
32. Kacharmina J.E., Crino P.B., Eberwine J. Preparation of cDNA from single cells and subcellular regions. cDNA Preparation Characterization 1999, vol. 303. pp. 3-18.
33. Ke L.D., Chen Z., Yung W.K.A. A reliability test of standard-based quantitative PCR: exogenous vs endogenous standards. Mol. Cell. Probes 2000, 14(2):127-135.
34. Liu W.H., Saint D.A. Validation of a quantitative method for real time PCR kinetics. Biochem. Biophys. Res. Commun. 2002, 294(2):347-353.
35. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-Delta Delta C) method. Methods 2001, 25(4):402-408.
36. Buzea C., Pacheco Blandino I.I., Robbie K. Nanomaterials and nanoparticles: sources and toxicity. Biointerphases 2007, 2(4):1-103.
37. 2) and zircon particles in synthetic body fluids. J. Biomater. Nanobiotechnol. 2012, 3:37-49.
38. 2 nanoparticles. Chemosphere 2011, 83:461-467.
39. Graham J.D., Clarke C.L. Physiological action of progesterone in target tissues. Endocr. Rev. 1997, 18:502-519.
40. Iwamasa J., Shibata S., Tanaka N., Matsuura K., Okamura H. The relationship between ovarian progesterone and proteolytic enzyme activity during ovulation in the gonadotrophin-treated immature rat. Biol. Reprod. 1992, 46:309-313.
41. Vendola K.A., Zhou J., Wang J., Bondy C.A. Androgens promote insulin-like growth factor-I, insulin-like growth factor-I receptor gene expression in the primate ovary. Hum. Reprod. 1999, 14:2328-2332.
42. Vendola K.A., Zhou J., Wang J., Famuyiwa O.A., Bievre M., Bondy C.A. Androgens promote oocyte insulin-like growth factor 1 expression and initiation of follicle development in the primate ovary. Biol. Reprod. 1999, 61:353-357.
43. Lyon M.F., Glenister P.H. Reduced reproductive performance in androgen-resistant Tfm/Tfm female mice. Proc. R. Soc. Lond. B: Biol. Sci. 1980, 208:1-12.
44. Richards J.S., Jonassen J.A., Rolfes A.I., Kersey K., Reichert L.E. Adenosine 3',5'-monophosphate, LH receptor and progesterone during granulosa cell differentiation: effects of oestradiol and FSH. Endocrinology 1979, 104:765-770.
45. Richards J.S., Rolfes A.I. Hormonal regulation of cyclic AMP binding to specific receptor proteins in rat ovarian follicles. J. Biol. Chem. 1980, 225:5481-5489.
46. Hockenbery D.M., Oltvai Z.N., Yin X.M., Milliman C.L., Korsmeyer S.J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993, 75:241-251.
47. Nel A., Xia T., Madler L., Li N. Toxic potential of materials at the nanolevel. Science 2006, 311(5761):622-627.
48. Ueda S., Masutani H., Nakamura H., Tanaka T., Ueno M., Yodoi J. Redox control of cell death. Antioxid. Redox Signal. 2002, 4(3):405-414.
49. Ott M., Gogvadze V., Orrenius S., Zhivotovsky B. Mitochondria, oxidative stress and cell death. Apoptosis 2007, 12(5):913-922.
50. Sun Q.Q., Tan D.L., Zhou Q.P., Liu X.R., Cheng Z., Liu G., Zhu M., Sang X.Z., Gui S.X., Cheng J., Hu R.P., Tang M., Hong F.S. Oxidative damage of lung and its protective mechanism in mice caused by long-term exposure to titanium dioxide nanoparticles. J. Biomed. Mater. Res. A 2012, 100(10):2554-2562.
51. Grollman A.P., Moriya M. Mutagenesis by 8-oxoguanine: an enemy within. Trends Genet. 1993, 9:246-249.
52. Evans M.D., Dizdaroglu M., Cooke M.S. Oxidative DNA damage and disease: induction, repair and significance. Mutat. Res. 2004, 567:1-6.
53. Pilger A., Rüdiger W.H. 8-Hydroxy-2'-deoxyguanosine as a marker of oxidative DNA damage related to occupational and environmental exposures. Int. Arch. Occup. Environ. Health 2006, 80:1-15.
54. Ishida M., Chang K.T., Hirabayashi I., Nishihara M., Tkahashi M. Cloning of mouse 20a-hydroxysteroid dehydrogenase cDNA and its mRNA localization during pregnancy. J. Reprod. Dev. 1999, 45:321-329.
55. Krozowski Z. The short-chain alcohol dehydrogenase superfamily: variations on a common theme. J. Steroid Biochem. Mol. Biol. 1994, 51:125-130.
56. Jornvall H., Persson B., Krook M., Atrian S., Gonzalez-Duarte R., Jeffery J., Ghosh D. Short-chain dehydrogenases/reductases (SDR). Biochemistry 1995, 34:6003-6013.
57. Penning T.M. Molecular endocrinology of hydroxysteroid dehydrogenases. Endocr. Rev. 1997, 18:281-305.
58. Mao J., Duan R.W., Zhong L., Gibori G., Azhar S. Expression, purification and characterization of the rat luteal 20 alpha-hydroxysteroid dehydrogenase. Endocrinology 1997, 138:182-190.
59. Perez G.I., Robles R., Knudson C.M., Flaws J.A., Korsmeyer S.J., Tilly J.L. Prolongation of ovarian lifespan into advanced chronological age by Bax-deficiency. Nat. Genet. 1999, 21:200-203.
60. Gougeon A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr. Rev. 1996, 17:121-155.
61. Johnson A.L. Intracellular mechanisms regulating cell survival in ovarian follicles. Anim. Reprod. Sci. 2003, 78:185-201.
62. Tilly J.L., Kowalski K.I., Johnson A.L., Hsueh A.J.W. Involvement of apoptosis in ovarian follicular atresia and postovulatory regression. Endocrinology 1991, 129:2799-2801.
63. HughesF F.M., Gorospe W.C. Biochemical identification of apoptosis (programmed cell death) in granulosa cells: evidence for a potential mechanism underlying follicular atresia. Endocrinology 1991, 129:2415-2422.
64. Hsueh A.J.W., Eisenhauer K., Chun S.Y., Hsu S.Y., Billig H. Gonadal cell apoptosis. Recent Prog. Horm. Res. 1996, 51:433-455.
65. Spector M.S., Desnoyers S., Hoeppner D.J., Hengartner M.O. Interaction between the C. elegans cell-death regulators CED-9 and CED-4. Nature 1997, 385:653-656.
66. Yuan J., Horvitz H.R. The Caenorhabditis elegans cell death gene ced-4 encodes a novel protein and is expressed during the period of extensive programmed cell death. Development 1992, 116:309-320.
67. Yuan J., Shaham S., Ledoux S., Ellis H.M., Horvitz H.R. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1-converting enzyme. Cell 1993, 75:641-652.
68. Hengartner M.O., Horvitz H.R.C. Elegans cell survival gene ced-9 encodes a functional homolog of the mammalian protooncogene bcl-2. Cell 1994, 76:665-676.
69. Puthalakath H., Villunger A., O'Reilly L.A., Beaumont J.G., Coultas L., Cheney R.E., Huang D.C., Strasser A. BMF: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis. Science 2001, 293:1829-1832.
70. Kanda H., Miura M. Regulatory roles of JNK in programmed cell death. J. Biochem. 2004, 136:1-6.
71. Lei K., Davis R.J. JNK phosphorylation of Bim-related members of the BCL2 family induces Bax-dependent apoptosis. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:2432-2437.